Head-to-head · WeighScore
AHBARx vs Remi Meds
By GLP-1 ScorecardUpdated
Score comparison
AHBARx has the higher recorded score — 64.2/100 to 48.4/100.
AHBARx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AHBARx shows the first-order and refill charges for one-, three- and six-month injection plans. Ask how the monthly membership terms apply to the plan you select.
Before you choose
Before comparing the headline prices, the AHBARx review and the Remi Meds review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, AHBARx vs The Edit and CoreAge Rx vs Remi Meds compare each of them with another graded program, and the list of alternatives to AHBARx ranks the programs closest to AHBARx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the SnagRx review covers one graded close to these two, at 57.9/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AHBARx | Remi Meds |
|---|---|---|
| WeighScore | 64.2/100 | 48.4/100 |
| Grade | C | C |
| Site position | #260 | #510 |
| Semaglutide | Selected quote required: 1-month selector shows $162 first order and $249 refill | $249/mo (0.25 mg dose, compounded) |
| Tirzepatide | Selected quote required: 1-month selector shows $227 first order and $349 refill | $349/mo (2.25 mg dose, compounded) |
| Coverage | Confirm eligibility for the selected treatment | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Public plan selectors show the first and repeat charges for each supply period
- The six-month offer separates the billing interval from the shipment interval
- Product pages say refills are reviewed during follow-up consultations
What to consider
- The terms describe a monthly weight-loss membership; the selector does not settle whether it adds a separate charge for a specific plan
- The cancellation terms contain unfinished contact and pharmacy placeholders
- The terms say unshipped medication will not be sent after cancellation; confirm how unused prepaid amounts are handled
- AnazaoHealth, named in the Help Center as a partner, is the subject of an FDA warning letter issued August 2021 to “AnazaoHealth Corporation” of Las Vegas, Nevada. It is a disclosure about a supplier; AHBARx carries no warning letter of its own
Strengths
- Names its compounding pharmacy (Strive Pharmacy, Gilbert AZ) — stronger transparency than peers
- LegitScript verification badge on the homepage
- Publishes 503A FDCA compliance language on the tirzepatide page
- Per-dose-tier pricing fully shown — no 'as low as' floor-only obfuscation
- Operating corporate entity disclosed (T-C Health Co)
What to consider
- No named medical director, founder, or physician on any public page
- States served not listed — 'nationwide' claim with no per-state detail
- Clinical care runs through Beluga Health, a network a 2026 StatNews analysis tied to many FDA-warned GLP-1 companies (Remi Meds itself not FDA-warned)
- Year founded and corporate history are opaque
- Two phone numbers and a secondary 'Rekindle RX' email hint at shared infrastructure
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.